How to manage Pseudomonas aeruginosa infections

Matteo Bassetti(University of Udine), Benoît Guéry(University of Lausanne)

Drugs in Context

May 29, 2018

10.7573/dic.212527

Cited by 743

Related Papers

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

|Clinical Infectious Diseases|2019|2.8k

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

|JAMA|2018|761

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

|The Lancet Respiratory Medicine|2014|648

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>

|Clinical Infectious Diseases|2018|351

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study

|Clinical Infectious Diseases|2021|264